- Proton Pump Inhibitors Should be Used with Caution in Critically Ill Patients to Prevent the Risk of Clostridium difficile Infection
-
Min JH, Kim YS
- KMID: 2412032
- Gut Liver.
- 2016 Jul;10(4):493-494.
- doi: 10.5009/gnl16216
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Proton Pump Inhibitor Use before Percutaneous Endoscopic Gastrostomy Is Associated with Adverse Outcomes
-
Im JP, Cha JM, Kim JW, Kim SE, Ryu DY, Kim EY, Kim ER, Chang DK, Small Intestine Research Group of the Korean Association for the Study of Intestinal Disease (KASID)
- KMID: 1774557
- Gut Liver.
- 2014 May;8(3):248-253.
BACKGROUND/AIMS: Knowledge of the risk factors associated with adverse outcomes after percutaneous endoscopic gastrostomy (PEG) may be helpful for developing PEG recommendations. The purpose of this study was to identify... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk of Clostridium difficile Infection with the Use of a Proton Pump Inhibitor for Stress Ulcer Prophylaxis in Critically Ill Patients
-
Ro Y, Eun CS, Kim HS, Kim JY, Byun YJ, Yoo KS, Han DS
- KMID: 2412047
- Gut Liver.
- 2016 Jul;10(4):581-586.
- doi: 10.5009/gnl15324
BACKGROUND/AIMS: Proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RAs) are commonly prescribed for stress ulcer prophylaxis (SUP) in critically ill patients. Several studies have suggested that the use of... -
- CITED
-
- Close
- SHARE
-
- Close
- Proton Pump Inhibitor-responsive Esophageal Eosinophilia: An Overview of Cases from One University Hospital Center
-
Ahn B, Lee DH, Lee CM, Hwang JJ, Yoon H, Shin CM, Park YS, Kim N
- KMID: 2373422
- Korean J Gastroenterol.
- 2016 Apr;67(4):178-182.
- doi: 10.4166/kjg.2016.67.4.178
BACKGROUND/AIMS: Eosinophilic esophagitis (EoE) is a chronic, immune/antigen-mediated esophageal disease, with eosinophilic infiltration limited to the esophagus. A minority of EoE patients respond well to proton pump inhibitor (PPI) therapy... -
- CITED
-
- Close
- SHARE
-
- Close
